ADMA Biologics Inc header image

ADMA Biologics Inc

ADMA

Equity

ISIN US0008991046 / Valor 20794750

NASDAQ (2024-09-18)
USD 19.32+3.26%

ADMA Biologics Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

ADMA Biologics Inc is a biopharmaceutical company focused on the development, manufacturing, and commercialization of human plasma-derived immunoglobulins. The company specializes in the collection of human plasma, which is a critical component in the creation of therapies aimed at treating and preventing various diseases. Through its ADMA BioCenters, the company operates a network of FDA-regulated facilities dedicated to the safe and efficient collection of high-quality human plasma. This plasma is then utilized in the production of ADMA's proprietary immunoglobulin products, which are designed to address unmet medical needs in immune-deficient patients and other populations vulnerable to infectious diseases. By controlling the process from plasma collection to product manufacturing, ADMA Biologics ensures a consistent and reliable supply of specialized therapeutic products.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

431%1Y
1,398%3Y
265%5Y

Performance

53.0%1Y
58.8%3Y
69.9%5Y

Volatility

Market cap

4361 M

Market cap (USD)

Daily traded volume (Shares)

1,788,638

Daily traded volume (Shares)

1 day high/low

19.75 / 18.69

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Bio-Techne Corp
Bio-Techne Corp Bio-Techne Corp Valor: 25995847
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.63%USD 76.51
United Therapeutics Corp
United Therapeutics Corp United Therapeutics Corp Valor: 848383
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.70%USD 342.59
Qorvo Inc
Qorvo Inc Qorvo Inc Valor: 25588586
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.20%USD 99.80
ZoomInfo Technologies Inc
ZoomInfo Technologies Inc ZoomInfo Technologies Inc Valor: 52926985
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.36%USD 10.35
Kanzhun Limited
Kanzhun Limited Kanzhun Limited Valor: 111493503
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.73%USD 12.10
Bentley Systems Inc
Bentley Systems Inc Bentley Systems Inc Valor: 56786212
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.32%USD 49.97
Sarepta Therapeutics Inc
Sarepta Therapeutics Inc Sarepta Therapeutics Inc Valor: 19028527
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.54%USD 125.01
Cognex Corp
Cognex Corp Cognex Corp Valor: 919421
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.23%USD 38.48
F5 Inc
F5 Inc F5 Inc Valor: 812258
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.50%USD 213.57
Manhattan Associates Inc
Manhattan Associates Inc Manhattan Associates Inc Valor: 892878
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.23%USD 269.20